Changes of Natriuretic Peptides Predict Hospital Admissions in Patients With Chronic Heart Failure
- 1 April 2014
- journal article
- research article
- Published by Elsevier BV in JACC: Heart Failure
- Vol. 2 (2), 148-158
- https://doi.org/10.1016/j.jchf.2013.11.007
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Systematic differences between BNP immunoassays: Comparison of methods using standard protocols and quality control materialsClinica Chimica Acta; International Journal of Clinical Chemistry, 2013
- Natriuretic Peptide-Guided Therapy in Chronic Heart Failure: A Meta-Analysis of 2,686 Patients in 12 Randomized TrialsPLOS ONE, 2013
- Extended heart failure clinic follow-up in low-risk patients: a randomized clinical trial (NorthStar)European Heart Journal, 2012
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEuropean Heart Journal, 2012
- Drug and Device Effects on Peak Oxygen Consumption, 6-Minute Walk Distance, and Natriuretic Peptides as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection FractionCirculation: Heart Failure, 2011
- Acute Changes in N-Terminal Pro-B-Type Natriuretic Peptide During Hospitalization and Risk of Readmission and Mortality in Patients With Heart FailureThe American Journal of Cardiology, 2011
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trialsAmerican Heart Journal, 2009
- Usefulness of Temporal Changes in Neurohormones as Markers of Ventricular Remodeling and Prognosis in Patients With Left Ventricular Systolic Dysfunction and Heart Failure Receiving Either Candesartan or Enalapril or BothThe American Journal of Cardiology, 2005
- Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular HypertrophyHypertension, 1996